Atom Investors’s Repligen RGEN Stock Holding History

Atom Investors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,487	Closed	-$219K	–	535
2020 Q3	$219K	Buy	+1,487	New	+$213K	0.02%	340
2019 Q1	–	Sell	-15,061	Closed	-$794K	–	675
2018 Q4	$794K	Buy	+15,061	New	+$883K	0.08%	374

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Atom Investors's RGEN Position: Q4 2020 in Review

Atom Investors sold out of Repligen (RGEN) in Q4 2020, closing a stake of 1,487 shares — an estimated $219K sold.

Atom Investors first reported a position in RGEN in Q4 2018 and held it in 2 quarters. The position peaked at $794K in Q4 2018. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

Atom Investors reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
Atom Investors sold 1,487 Repligen shares in Q4 2020, an estimated $219K.
Atom Investors first reported a position in Repligen in Q4 2018 and held it in 2 quarters.
Atom Investors's Repligen position peaked at $794K in Q4 2018.
449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Atom Investors's 13F filing for Q4 2020, filed 16 Feb 2021.